Israel-based Aidoc announces the launch of an artificial intelligence (AI)-based automated activation solution that facilitates rapid risk assessment and care coordination for high-risk pulmonary embolism (PE) patients. Aidoc’s PE Care Coordination solution is U.S. FDA-cleared for triage and notification of PE.
The technology is “always on,” running behind the scenes and does not require physician activation. High-risk PE patients are automatically flagged after the scan is performed and a notification is sent simultaneously to all the relevant team members, including radiologists, pulmonologists, cardiologists, and vascular surgeons. Once the teams are alerted, the technology enables real-time image, data, and text-sharing, leading to improved patient management and care coordination.
The launch is part of an ongoing Aidoc partnership with the department of radiology and biomedical imaging at Yale School of Medicine and follows six months of clinical use led by the Yale radiology team.
“We have been using the first version of this solution for the last six months and have seen the real impact this has had on addressing patients that require treatment beyond anticoagulation,” says Irena Tocino, MD, FACR, professor and vice chair of medical informatics in the department of radiology and biomedical imaging at Yale School of Medicine (YSM). “Having this subset of patients routed simultaneously to multiple stakeholders has shown a reduction in time to treatment and clear improvements in patient outcomes.”
“The PE Response Team (PERT) was established to provide rapid risk assessment along with execution of the patient management strategy,” adds Akhil Khosla, MD, co-director of the PERT program in YSM’s department of internal medicine. “One of the challenges of establishing a PERT program is making sure the right information is in the hands of the right clinician. In Aidoc, we have a partner with the ability to bring deep integration of AI into these native workflows. The outcome leads to enhanced patient eligibility for novel therapies and makes a significant change to patient management.”
PE outcomes are highly variable. While some patients have excellent prognosis without any treatment, others may require invasive and urgent therapies, Aidoc officials say. Rapid risk assessment of acute PE cases is essential for the triage of patients, and a multidisciplinary approach to patient treatment and management can be the defining factor in their care, they add.